Skip to main content

Visit our other sites

jnj.com
jnjinnovation network
Quickfire Challenges

Main navigation

Home
About us
Partner with us
Blog
News
Challenges
Video hub
Connect with Us

News

Maintabs

All news
Press releases
In the media
Partner news
Social
Other News

Article view
List view

Refine by

Refine by

Type

JNJ Press releases
Other news
Partner news

Period

2022
2021
2020
(-) 2019
2018
2017
2016
2015
2014
2013
2012
2010
2009

Jan
Feb
Mar
(-) Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec

Locations & regions

East North America

Focus area

About JLABS

Clear filters

News

JNJ Press releases

Johnson & Johnson Innovation Announces Collaboration with National Academy of Medicine to Help People Live Longer, Healthier Lives

Read full story

HistoSonics, Non-Invasive Robotics Pioneer, Closes $54 Million Series C Financing

Read full story

New Johnson & Johnson Nurses Innovate QuickFire Challenge in Perioperative Care launched at AORN Expo

Read full story

JNJ Press releases

Johnson & Johnson Innovation and Children’s National Health System* to Launch JLABS @ Washington, DC at the new Children’s National Research and Innovation Campus in 2020

Read full story

BlackThorn Therapeutics Announces Positive Phase 1 Results for Its Selective KOR Antagonist, BTRX-335140

Read full story

Sidebar

Currently trending

Currently trending

Locus Biosciences Announces $35 Million Financing
VantAI Announces Multi-Year Protein Degrader Discovery Collaboration with Janssen
Bioasis Enters Into Research Collaboration With Janssen
Rondo Therapeutics Closes $67 Million Series A Financing to Advance Next-Generation Immuno-Oncology Platform for Solid Tumors
Biocom conference charts prospects for life sciences industry amid stock market volatility
Remix Therapeutics Enters Collaboration with Janssen to Advance Small Molecule Therapeutics Using REMaster Drug Discovery Platform to Modulate RNA Processing
VerImmune Inc Announces Research Collaboration with Janssen to Leverage its Unique Immuno-oncology Therapeutic Platform
Mersana Therapeutics Announces Research Collaboration and License Agreement with Janssen to Advance Novel Antibody-Drug Conjugates
CRISPR Therapeutics and ViaCyte, Inc. Announce First Patient Dosed in Phase 1 Clinical Trial of Novel Gene-Edited Cell Replacement Therapy for Treatment of Type 1 Diabetes (T1D)
Navitor Pharmaceuticals Announces Janssen Has Acquired Anakuria Therapeutics, Inc.

Trending

Trending

A JLABS Collaboration: DC4U

A JLABS Collaboration: Neurocast

Johnson & Johnson Innovation: Our Partnership Story